Global OTC Analgesics Market - Growth, Trends and Forecast 2017 - 2022 - Product Image

Global OTC Analgesics Market - Growth, Trends and Forecast 2017 - 2022

  • ID: 4388598
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 3
The global OTC Analgesics market accounted for a market value of USD XX billion in 2015. The market is expected to reach USD XX billion in 2016 and USD XX billion by 2021, growing at a CAGR of xx% during the forecast period till 2021.

The various OTC analgesics available are generally used for the treatment of headaches, fever, colds, flu, toothaches, arthritis, musculoskeletal injuries and disorders, and menstrual cramps. Topical OTC analgesics include menthol, camphor, capsaicin, and trolamine salicylate. OTC analgesics are available in both brand and generic formulations in tablets, capsules, gelcaps, powders, creams, ointments, suppositories, sprays, and patches.

The market will boost due to the fact that a large percentage of population thinks that branded products do better than generic OTC Analgesic drugs. Further they always choose premium priced branded ones when it comes to relieving aggravating pains. The Private label products are rising in sales at a rate higher than any other branded products. The total market of OTC Analgesic drugs is hence, rising continuously. The OTC drugs however are not always safe to use in larger quantities. Acetaminophen (APAP), one of the most commonly used OTC analgesics, causes acute liver failure in a large population of the United States. The FDA reported that a lot of patients tend to consume more than the dosage that is recommended. This increases the potential for adverse reactions.

The OTC Analgesic Drugs market has been segmented based on the type of the drugs used, their usage and application. The OTC Analgesics have been segmented based on the type of drug targets and include three general categories. The categories include Acetaminophen (Brand name: Tylenol), Non-Steroidal Anti-Inflammatory Drugs and Salicylates. NSAIDs involve Ibuprufen (Brand Name: Advil, Motrin), ketoprufen and Naproxen (Brand Name: Aleve) while Salicylates contain Aspirin (Ecotrin, Bayer), Magnesium Salicylate and Sodium Salicylate.

This report have been geographically segmented into North America, Europe, Asia-Pacific, Middle East & Africa and South America. The North American region have been further segmented into USA, Canada and Mexico. The Europe region have been sub-divided into Germany, France, UK, Spain, Italy, Scandinavia, Benelux and Rest of Europe. The Asia-Pacific market have been segmented into Japan, China, India, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of Middle East and Africa. The South American market have been segmented into Brazil, Argentina and rest of South America. North America accounts for the largest market share.

The current market lacks curative therapy that can act as a topical as well as a systemic treatment method and thus bringing innovative products and tapping the emerging economy will be a great opportunity for the market. The key players in the market are Pfizer, Sanofi, Boehringer Ingelheim, Novartis, Johnson & Johnson, Takeda, Sunovion Pharmaceuticals and Sun Pharma.

Key Deliverables:

Market analysis for the OTC Analgesic Drugs market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the Global OTC Analgesic Drugs market

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Study deliveratives
1.2 Market Definition
1.3 Review and forecast period years
1.4 General Study Assumptions
1.5 Report Description
2. RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Study timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Porters Five Force Analysis
5.2.1 Bargaining Power of suppliers
5.2.2 Bargaining power of buyers
5.2.3 Degree of competition
5.2.4 Threat of substitution
5.2.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Better performance of premium priced branded products
6.1.2 High performance from Private label analgesics
6.2 Market Restraints
6.2.1 Harmful side effects on continuous use
6.3 Market opportunities
6.3.1 To innovate Integrated topical and systemic treatments
6.4 Key Challenges
7. GLOBAL OTC ANALGESIC DRUGS MARKET -SEGMENTATION
7.1 BASED ON DRUG TYPE
7.1.1 Acetaminophen (Tylenol)
7.1.2 Non-steroidal Anti-inflammatory Drugs
7.1.2.1 Ibuprofen (Advil, Motrin)
7.1.2.2 Ketoprufen
7.1.2.3 Naproxen (Aleve)
7.1.2.4 Others
7.1.3 Salicylates
7.1.3.1 Aspirin (Ecotrin, Bayer)
7.1.3.2 Magnesium salicylate
7.1.3.3 Sodium salicylate
7.1.3.4 Others
8. Global OTC Analgesic Drugs market by Geography - Regional shares and forecast
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Italy
8.2.5 Spain & Portugal
8.2.6 Scandinavia
8.2.7 Benelux
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 Bayer
10.2 Sanofi
10.3 Boehringer Ingelheim
10.4 Novartis
10.5 Johnson & Johnson
10.6 Takeda Pharma
10.7 Sun Pharma
10.8 Others
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll